Drugs for Neglected Diseases initiative

@DNDi · Switzerland and Worldwide · joined 23 Feb 2011

International non-profit developing safe, effective, and affordable treatments for the most neglected patients. https://t.co/666r8GVfmr

24 680Followers

2 943Following

12 548Posts total

8KViews on collected posts

Últimas publicaciones

Drugs for Neglected Diseases initiative@DNDi11 Sep

🔬 212 R&D and access partner institutions in 47 countries 🧪 41 clinical trial sites in 16 countries 🔎 To learn more about our activities: https://t.co/FPAjkQcgit https://t.co/sva6NMMUE9

503 views · 7 likes · 0 reposts · 0 replies Open on X →

Drugs for Neglected Diseases initiative@DNDi10 Sep

DNDI-6148 is a promising drug candidate for #leishmaniasis and #Chagas disease. This study in @PLOSNTDs used data from healthy volunteers to better understand how the drug behaves in the body & support dose selection for upcoming clinical trials. https://t.co/fnTrje0TH5 552 views · 3 likes · 1 reposts · 0 replies Open on X →

Drugs for Neglected Diseases initiative@DNDi10 Sep

Can we tell sooner whether a #Chagas treatment is working? This study in @JIDJournal suggests MultiCruzi can detect early antibody changes after treatment, offering a promising way to assess treatment response long before conventional tests. https://t.co/12bhngkfVj 2K views · 10 likes · 3 reposts · 0 replies Open on X →

Drugs for Neglected Diseases initiative@DNDi9 Sep

Can oxfendazole help eliminate lymphatic filariasis? This Phase IIa proof‑of‑concept trial published in @SpringerNature will evaluate its safety & ability to target adult filarial worms, helping guide development of new treatments. https://t.co/19EcfOnE2r 414 views · 4 likes · 1 reposts · 0 replies Open on X →

Drugs for Neglected Diseases initiative@DNDi4 Mar 2025

https://t.co/9ZLHacA3kt

4.5K views · 14 likes · 5 reposts · 3 replies Open on X →

Frente a cuentas del mismo tamaño

4 publicaciones de los últimos 90 días, junto al rango de 10K–100K seguidores. por debajo de sus pares en alcance y en interacción.

Visualizaciones medianas528esta cuenta924mediana de 10K–100K

Alcance, %2.14%esta cuenta3.62%mediana de 10K–100K

Interacción, %0.97%esta cuenta1.52%mediana de 10K–100K

Métrica	Esta cuenta	Mediana de 10K–100K	Proporción
Visualizaciones medianas por publicación	528	924	0.57×
Alcance (visualizaciones ÷ seguidores)	2.14%	3.62%	0.59×
Tasa de interacción	0.97%	1.52%	0.64×

Otras cuentas de este rango → Comparar con otra cuenta → Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

4.5K4 Mar

4149 Sep

2K10 Sep

552

50311 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.52%4 Mar

1.21%9 Sep

0.64%10 Sep

0.72%

1.39%11 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes67.9%38 in total

Reposts17.9%10 in total

Replies5.4%3 in total

Quotes1.8%1 in total

Bookmarks7.1%4 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.